International forum of allergy & rhinology
The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.
Jens Tidemandsen, Vibeke Backer, Anne Sophie Homøe, Thomas H L Jensen, Kasper Aanæs, Howraman Meteran, Morten Hostrup, Lukas Moesgaard, Christiane Haase, Peter G Gibson
Published: 202510.1002/alr.70073
Abstract
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease often associated with asthma. The global airway hypothesis suggests bidirectional inflammatory interactions between upper and lower airways. Mepolizumab, a…
Preview only. Read the full abstract at the source